<p>Combined marker (EZH2, BMI1, SUZ12 and H3K27me3) expression groups were divided into three patient groups: group 1, groups 2–4 and group 5. The numbers of patients in the individual patient groups were: group 1 (n = 28), group 2 (n = 59), group 3 (n = 55), group 4 (n = 74) and group 5 (n = 31). Kaplan-Meier curves were made for overall survival (A) and cumulative incidence curves are shown for disease-free survival (B), locoregional recurrence-free survival (C) and distant recurrence-free survival (D). 5-year survival rates are given for each patient group. Tables below the curves indicate the numbers at risk (#) per group for the different time points.</p
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...
<p>Kaplan-Meier curves of overall survival stratified by grouping, using cancer-related death as the...
<p>A. By lymph node involvement, B. By chr3p25, chr11p11 gain. C. By lymph node involvement and chr3...
<p>Kaplan-Meier survival curves were estimated for each event and the curves of the different groups...
<p>Kaplan-Meier curves of overall survival by histology in (A) all patients, (B) patients with non-m...
<p>(A) The survival rate in men (Low group: 96.2% at 1 year and 78.7% at 5 years; High group: 85.5% ...
<p>Kaplan-Meier curves for disease-free survival by treatment arm are shown for patients with stage ...
<p>Kaplan-Meier survival curves for different treatment protocols and biomarker as well as the impac...
<p>Standard Kaplan-Meier (KM) curves and cumulative incidence curves from competing risk (CR) analys...
<p>Survival curves based on Kaplan-Meier estimates of (a) overall survival and (b) disease-specific ...
<p>Kaplan-Meier curves of overall survival A) All patients, B) By Culine prognostic risk group, C) B...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
Kaplan-Meier curves of overall survival for patients stratified by (A) FN intensity (0 vs > 0) and (...
<p>OS in 222 patients (A). OS in the overall population and by MICA expression (B). OS in the overal...
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...
<p>Kaplan-Meier curves of overall survival stratified by grouping, using cancer-related death as the...
<p>A. By lymph node involvement, B. By chr3p25, chr11p11 gain. C. By lymph node involvement and chr3...
<p>Kaplan-Meier survival curves were estimated for each event and the curves of the different groups...
<p>Kaplan-Meier curves of overall survival by histology in (A) all patients, (B) patients with non-m...
<p>(A) The survival rate in men (Low group: 96.2% at 1 year and 78.7% at 5 years; High group: 85.5% ...
<p>Kaplan-Meier curves for disease-free survival by treatment arm are shown for patients with stage ...
<p>Kaplan-Meier survival curves for different treatment protocols and biomarker as well as the impac...
<p>Standard Kaplan-Meier (KM) curves and cumulative incidence curves from competing risk (CR) analys...
<p>Survival curves based on Kaplan-Meier estimates of (a) overall survival and (b) disease-specific ...
<p>Kaplan-Meier curves of overall survival A) All patients, B) By Culine prognostic risk group, C) B...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
Kaplan-Meier curves of overall survival for patients stratified by (A) FN intensity (0 vs > 0) and (...
<p>OS in 222 patients (A). OS in the overall population and by MICA expression (B). OS in the overal...
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...
<p>Kaplan-Meier curves of overall survival stratified by grouping, using cancer-related death as the...
<p>A. By lymph node involvement, B. By chr3p25, chr11p11 gain. C. By lymph node involvement and chr3...